| Literature DB >> 34335848 |
Yan-Wen Liu1, Yung-Tang Hsu1, Wen-Chin Lee2, Ming-Yen Tsai1.
Abstract
Renal replacement therapy is an important therapy for prolonging life in end-stage renal disease (ESRD) populations, and, in Taiwan, hemodialysis (HD) is the choice for most patients with ESRD. Although HD is effective for prolonging life, it is sometimes associated with complications that patients and doctors have to cope with every day, such as intradialytic hypotension, dialysis disequilibrium syndrome, and muscle cramps. Traditional Chinese medicine (TCM) is a complementary and alternative therapy that has been recognized for its efficacy in treating a variety of diseases by the World Health Organization. Nowadays, the clinical practice of TCM for HD-related complications has received attention for its effectiveness and safety. In this article, we summarize the TCM viewpoint and different TCM interventions for HD-related complications, such as Chinese herbal medicine, acupuncture, herbal acupoint therapy, auricular acupoints, and moxibustion. In the ESRD population, TCM is able to balance Yin and Yang, prevent cardiovascular accidents, control blood pressure, and relieve pain. More importantly, TCM may also improve common HD-related complications such as uremic symptoms, imbalance of electrolyte and fluid status, insomnia, and malnutrition. The mechanism of TCM is considered related to the regulation of autonomous functions and the activation of biologically active chemical substances. According to the studies noted in this review article, TCM has been proven effective for HD-related complications. However, more well-designed and rigorous research will be necessary to reveal the underlying mechanisms in the future.Entities:
Year: 2021 PMID: 34335848 PMCID: PMC8292057 DOI: 10.1155/2021/9953986
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Description of traditional herbal medicine viewpoints and treatments for acute hemodialysis-related complications in this review.
| Complication | TCM disease | Symptom and sign | Etiology and pathogenesis | Method | Treatment | Reference | |
|---|---|---|---|---|---|---|---|
|
| Dizziness syndrome/juc collapse/asthenic disease | Cold clammy limbs, general weakness, shortness of breath, and sweating | Deficiency syndrome | Yang | NA | NA | [ |
| Excess syndrome | Blood stasis, dampness, windiness, and water vapor | ||||||
| Early stage | Deficiency of both | CHM | Sheng Mai Yin, | [ | |||
| Late stage |
| Shen Fu decoction | |||||
| Deficiency of kidney-Yang | HAT |
| [ | ||||
| Deficiency in origin and excess in superficiality | Dampness and heat with deficiency of both | CHM | Sheng Mai Yin and Si Miao San decoction | [ | |||
|
| |||||||
|
| Dizziness syndrome | Headaches, fatigue or confusion, vision problems, chest pain | Hyperactivity of liver-Yang | Acu | Sanyinjiao (SP6), Taixi (KI3), and Shenguan (LE44) | [ | |
| Deficiency of kidney-Yin | EA | Erbeixin (P1), Erjian (EX-HN6), liver (CO12), Jiaowoshang (TF1) | [ | ||||
| Deficiency of Yin and Yang | Spleen (CO13), kidney (CO10), Erbeipi (P3), Erbeigou (PS) | ||||||
| Interior retention of phlegm and dampness | Sanjiao (CO17), spleen (CO13), Erbeipi (P3), Erbeigou (PS), Jiaogan (AH6a) | ||||||
| Deficiency of Yang floating upward | HAT |
| |||||
|
| |||||||
|
| Jin Bi/Bi-syndrome | Tonic contraction and myalgia | Stagnation of coldness in the muscles | Mox | Zusanli (ST36), Sanyinjiao (SP6), and Guanyuan (CV4) | [ | |
| Malnutrition of liver, spleen, and kidney | Acupressure | Hegu (LI4), Taichong (LR3), Chengshan (BL57), Chengjin (BL56), Yanglingquan (GB34), and Zusanli (ST36) | [ | ||||
| Chengshan (BL57), Shuigou (GV26), Taichong (LR3), Guanyuan (CV4), Qihai (CV6), Yongquan (KI1), Lieque (LU7), and Taiyuan (LU9) | [ | ||||||
| Deficiency of liver and kidney | Acu | Ququan (LR8), Fuliu (KI7), Guanyuan (CV4), Qimen (LR14), Ganshu (BL18), and Shenshu (Bl23) | [ | ||||
| Deficiency of Yin and blood, malnutrition of the tendons and channels | CHM | Shao Yao Gan Cao Tang | [ | ||||
|
| |||||||
|
| Retching/hiccup/vomiting | Nausea, vomiting, anorexia, allotriogeusia, headache | Deficiency of spleen and kidney | HAT |
| [ | |
| Acu | Zhongwan (CV12), Neiguan (PC6), and Zusanli (ST36) | ||||||
| Cold blocking the channels due to blood deficiency, incoordination between the spleen and liver resulting in rebellious | CHM | Dang Gui Si Ni Tang plus | [ | ||||
|
| |||||||
|
| True headache | Liver dysfunction in dispersion, deficiency of | EA | Shenmen (TF4), subcortex (AT4), occiput (AT3), kidney (CO10), liver (CO12), and spleen (CO13) | [ | ||
|
| |||||||
|
| Chest impediment | Pressure, fullness, burning, or tightness in chest | Deficiency in origin and excess in superficiality | Deficiency of kidney- | CHM | She Xiang Bao Xin Pill | [ |
|
| |||||||
|
| Headache/dizziness syndrome/vomiting/convulsion diseases | Nausea, headache, vomiting, restlessness, and even seizures and coma | Deficiency of spleen and kidney, insufficient gasification causes phlegm turbidity retention | CHM | Wu Ling San | [ | |
| CHM | Wen Yang Li Shui Tang | [ | |||||
| Acu | Taichong (LR3), Fengchi (GB20), Baihui (GV20), Sishencong (EXHN 1), Xingjian (LR2), Neiting (ST44), and Xiaxi (GB43) | [ | |||||
Acu: acupuncture; CHM: Chinese herbal medicine; EA: ear acupuncture; HAT: herbal acupoint therapy; Mox: moxibustion; NA: not applicable.
Figure 1Application of Chinese herbal medicine formulas to hemodialysis-related complications: mechanisms and management (IVF: intravenous fluid; ICF: intracellular fluid).
Summary of Chinese herbal medicine formulas: main effects, mechanisms, and possible toxicity profiles.
| Name | Composition | Design | Dosage and route of administration | Main effect | Mechanism | Toxicity profiles |
|---|---|---|---|---|---|---|
| Shen Fu injection (SFI) [ |
| Case | 20–30 ml, IVD | ↑BP | Increment of heart rate and cardiac contractility | Aconite poisoning with arrhythmia and shock [ |
|
| ||||||
| Sheng Mai Yin (SMY) and modified Si Miao San (SMS) decoction [ |
| Case control | A: SMY + SMS 200 ml, BID PO plus Sheng Mai injection (SMI) 30 ml, IVD 12 weeks; B: SMI 30 ml, IVD 12 weeks | ↑BP, hemoglobin, and albumin ↓CRP | Elevation of BP and plasma colloid osmotic pressure, improvement of the microinflammatory state | Not reported |
|
| ||||||
| Shao Yao Gan Cao Tang (SYGCT) [ |
| Case series and animal | 6 GM, PO QD 4 weeks | ↓Episodes of muscle cramp, ↑sural NCV, ↓contraction of skeletal muscles in rats | Direct inhibition of muscle contraction due to nerve stimulation | Mild hyperkalemia (5.5–6 mEq/L) [ |
| Shao Yao Gan Cao Tang (SYGCT) [ | UCT | A: 2.5 g, PO once at home; B: 2.5 g, PO once before HD 4 weeks | ↓Episodes and duration of muscle cramp, ↓amount of saline infusion, ↑VAS | Inhibitory effect on excessive muscle contraction and promotion of plasma refilling in muscle | ||
|
| ||||||
| Dang Gui Si Ni Tang (DGSNT) plus |
| Case | 3-4 g, PO TID 14 days | ↓N/V, BUN | Reduction of BUN level, balancing of the PH value of the GI tract |
|
|
| ||||||
| She Xiang Bao Xin Pill (SXBXP) [ |
| RCT | A: SXBXP 2 pills, SL PRN; B: isosorbide dinitrate 10 mg, SL PRN; C: SXBXP 2 pills + isosorbide dinitrate 5 mg, SL PRN | ↓Chest pain and associated symptoms, ↓BP and HR | Dilation of coronary artery, increment of myocardial contractility, and reduction of heart rate | Coagulation dysfunction [ |
|
| ||||||
| Wu Ling San (WLS) decoction [ |
| RCT | A: WLS 100–150 ml, BID, PO once before HD; B: 50% glucose 40–60 ml, IVD once before HD | ↓DDS symptoms (headache, nausea, anxiety, blurred vision) | Improvement of cerebral edema and decrement of CSF pressure | Not reported |
|
| ||||||
| Wen Yang Li Shui tang (WYLST) [ |
| RCT | A: 20 GM, PO once upon DDS attack; B: Conventional therapy upon DDS attack | ↑Response rate of DDS symptoms (96% versus 80%) | Increment of plasma osmolality and simultaneous decrement of further osmotic shift to brain | Not reported |
BID: twice daily; BP: blood pressure; BUN: blood urea nitrogen; CRP: C-reactive protein; CSF: cerebrospinal fluid; DDS: dialysis disequilibrium syndrome; EKG: electrocardiogram; EMG: electromyogram; GI: gastrointestinal; HR: heart rate; IDH: intradialytic hypotension; IVD: intravenous drip; NA: not applicable; NCV: nerve conduction velocities; N/V: nausea and vomiting; PH: potential of hydrogen; PO: oral; PRN: pro re nata; QD: once daily; RCT: randomized controlled trial; SL: sublingual; TID: three times daily; UCT, uncontrolled trial; VAS: visual analogue scale.